Announcements Trials

Browse Landscape

Status

Recruiting 44 Completed 34 Active not recruiting 25 Terminated 8 Not yet recruiting 5 Withdrawn 4 Unknown 3 Enrolling by invitation 1 Available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

ribociclib 1 leronlimab 1 gedatolisib 1 Proton Pump Inhibitors 1 Hydrocortisone 1 Alpelisib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Available × ribociclib × Breast × Clear all

NCT05038631 2026-04-13

Managed Access Programs for LEE011, Ribociclib

Novartis

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡